UnitedHealth Group (NYSE:UNH – Get Free Report) had its target price decreased by analysts at Truist Financial from $625.00 to $610.00 in a report issued on Monday, MarketBeat Ratings reports. The firm currently has a “buy” rating on the healthcare conglomerate’s stock. Truist Financial’s target price suggests a potential upside of 18.71% from the stock’s previous close.
A number of other research firms have also issued reports on UNH. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Monday, December 9th. Hsbc Global Res lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Oppenheimer upped their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Piper Sandler decreased their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Finally, Bank of America decreased their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $627.58.
View Our Latest Analysis on UNH
UnitedHealth Group Trading Up 0.0 %
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue was up 9.2% on a year-over-year basis. During the same period last year, the firm posted $6.56 earnings per share. Equities analysts predict that UnitedHealth Group will post 27.61 earnings per share for the current year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Range Financial Group LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth about $285,000. One Wealth Capital Management LLC acquired a new stake in UnitedHealth Group in the 4th quarter worth approximately $584,000. Diversified Trust Co raised its position in shares of UnitedHealth Group by 14.1% in the fourth quarter. Diversified Trust Co now owns 49,745 shares of the healthcare conglomerate’s stock valued at $25,164,000 after purchasing an additional 6,158 shares during the period. Bangor Savings Bank grew its stake in UnitedHealth Group by 7.5% in the 4th quarter. Bangor Savings Bank now owns 804 shares of the healthcare conglomerate’s stock valued at $407,000 after buying an additional 56 shares during the last quarter. Finally, Canandaigua National Trust Co of Florida lifted its position in UnitedHealth Group by 16.0% during the 4th quarter. Canandaigua National Trust Co of Florida now owns 875 shares of the healthcare conglomerate’s stock worth $443,000 after acquiring an additional 121 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Health Care Stocks Explained: Why You Might Want to Invest
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Quiet Period Expirations Explained
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.